The healthcare automation firm is selling its population health and 340B lines, which represent less than 3 percent of its revenue, as they “are no longer aligned with the company’s product strategy,” the spokesperson said. Meanwhile, two health systems gave notice in August and September that they were ending their contracts with Olive.
The news of the asset sales was first reported Oct. 4 by Axios. The spokesperson refuted claims in the article that the company was divesting 15 to 30 percent of its health system product line to sibling company Rotera and that 10 health systems had ceased doing business with the firm.
In late September, three top executives departed the company, which laid off 450 staffers in July.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
